Treatment with IL-12 not only induced massive accumulation of immune cells, like CD8+ T leukocytes, macrophages, and dendritic cells in tumors in situ, but it also apparently reduced the number of angiogenic blood vessels within tumor tissues. This evidence concerns the gene CD8A and neoplasm.